Clearmind Medicine, Inc. (CMND)
0.715
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.71
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Market Cap : 1.534M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.534M |
| October 01, 2026 | 1.536M |
| September 30, 2026 | 1.727M |
| September 29, 2026 | 1.741M |
| September 28, 2026 | 1.690M |
| September 25, 2026 | 1.723M |
| September 24, 2026 | 1.738M |
| September 23, 2026 | 1.823M |
| September 22, 2026 | 1.676M |
| September 21, 2026 | 1.696M |
| September 18, 2026 | 1.715M |
| September 17, 2026 | 1.841M |
| September 16, 2026 | 1.729M |
| September 15, 2026 | 1.854M |
| September 14, 2026 | 2.025M |
| September 11, 2026 | 2.074M |
| September 10, 2026 | 2.106M |
| September 09, 2026 | 2.274M |
| September 08, 2026 | 2.210M |
| September 04, 2026 | 1.182M |
| September 03, 2026 | 1.732M |
| September 02, 2026 | 1.885M |
| September 01, 2026 | 1.865M |
| August 31, 2026 | 1.977M |
| August 28, 2026 | 1.794M |
| Date | Value |
|---|---|
| August 27, 2026 | 1.845M |
| August 26, 2026 | 1.753M |
| August 25, 2026 | 1.743M |
| August 24, 2026 | 1.712M |
| August 21, 2026 | 1.773M |
| August 20, 2026 | 1.763M |
| August 19, 2026 | 1.946M |
| August 18, 2026 | 1.997M |
| August 17, 2026 | 1.926M |
| August 14, 2026 | 1.896M |
| August 13, 2026 | 1.885M |
| August 12, 2026 | 1.682M |
| August 11, 2026 | 1.641M |
| August 10, 2026 | 1.631M |
| August 07, 2026 | 1.661M |
| August 06, 2026 | 1.783M |
| August 05, 2026 | 1.794M |
| August 04, 2026 | 1.743M |
| August 03, 2026 | 1.661M |
| July 31, 2026 | 1.722M |
| July 30, 2026 | 1.651M |
| July 29, 2026 | 1.488M |
| July 28, 2026 | 1.488M |
| July 27, 2026 | 1.651M |
| July 24, 2026 | 1.641M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 7.101M |
| NervGen Pharma Corp. | 189.41M |
| Milestone Pharmaceuticals, Inc. | 100.81M |
| Lexaria Bioscience Corp. | 4.759M |
| Target Group, Inc. (Canada) | 0.4319M |
Market Cap Related Metrics
| Price to Book Value | 0.1184 |
| Price | 0.715 |
| Earnings Yield | -12.33K% |